Doctors Note Logo

Published on: 9/22/2026

What is cyclobenzaprine used for, and how long does it last?

Cyclobenzaprine (Flexeril, Amrix) is a prescription muscle relaxant used short term, usually 2 to 3 weeks, to ease muscle spasms, stiffness, and pain from acute strains, sprains, back or neck injuries, and it is sometimes prescribed off label for fibromyalgia or tension headaches. A single immediate release dose typically starts working within about 1 hour, lasts roughly 4 to 6 hours, and is dosed up to three times daily, while the extended release capsule lasts about 24 hours; the drug's half life ranges from about 8 to 37 hours, so it can linger in your system for several days and cause next day drowsiness. How long the effects last for you depends on several factors, including your age, liver function, dose and formulation, alcohol use, and other medications such as opioids, benzodiazepines, antidepressants, or MAO inhibitors, so see below for the important details and warnings you should consider before taking it. Because muscle spasms can stem from anything from a minor strain to a pinched nerve, disc problem, or another underlying condition, knowing what is actually causing your pain matters more than just masking it. Take a free, instant, online symptom check to better understand what may be driving your symptoms and to get clear guidance on your next steps.

Last reviewed for medical accuracy: 09/22/2026

answer background

Explanation

Cyclobenzaprine: What It’s Used For and How Long It Lasts

Cyclobenzaprine is a prescription muscle relaxant commonly used to help ease muscle spasms and the pain that comes with them. It’s often part of a broader treatment plan that includes rest, physical therapy, and other measures.

What Is Cyclobenzaprine?

Cyclobenzaprine belongs to a class of drugs known as skeletal muscle relaxants. Though its exact mechanism isn’t fully understood, it appears to work on the central nervous system (CNS) to reduce muscle hyperactivity. It does not act directly on the muscles themselves, but rather at brainstem levels to decrease the signals that cause spasms.

Approved Uses

Cyclobenzaprine is primarily prescribed for:

  • Acute muscle spasms: Usually arising from strains, sprains or injuries to muscle groups of the neck, back or limbs
  • Short-term relief: Most guidelines recommend use for no longer than 2–3 weeks

Off-label uses (based on clinical judgment) may include certain types of fibromyalgia or chronic tension headache, but these are not formally approved by regulatory agencies.

Forms and Dosage

Cyclobenzaprine is available in two main formulations:

  1. Immediate-Release Tablets

    • Strengths: 5 mg and 10 mg
    • Typical Dose: 5–10 mg, three times daily
    • Duration: Usually prescribed for up to 2–3 weeks
  2. Extended-Release Capsules (Amrix®)

    • Strengths: 15 mg and 30 mg
    • Typical Dose: 15–30 mg once daily
    • Duration: Also limited to about 2–3 weeks

Your doctor will choose the form and dose based on factors like the severity of your spasms, other medical conditions, and how you respond to treatment.

How Long Does Cyclobenzaprine Last?

Understanding how long you’ll feel relief involves several points:

  • Onset of Action: Most people start to notice muscle-relaxing effects within 1 hour of taking a dose.
  • Peak Effect: Blood levels peak around 3–8 hours after a single dose.
  • Half-Life: The average elimination half-life is about 18 hours, though it can range from 8 to 37 hours depending on age and liver function.
  • Duration of Action:
    • Immediate‐release: Up to 12 hours of relief per dose, but sedation or residual drowsiness may last into the next day
    • Extended‐release: Designed to provide smoother control over 24 hours

Factors That Influence Duration

  • Age: Older adults may clear the drug more slowly, prolonging effects.
  • Liver Function: Impaired liver function can lead to higher blood levels and longer duration.
  • Interactions: Drugs that affect liver enzymes can speed up or slow down cyclobenzaprine metabolism.

Common Side Effects

Most side effects are mild to moderate and tend to improve as your body adjusts:

  • Drowsiness or sedation
  • Dry mouth
  • Dizziness
  • Fatigue
  • Constipation

If you experience persistent or bothersome effects, talk to your doctor about adjusting the dose or trying an alternative.

Important Precautions

Before starting cyclobenzaprine, let your doctor know if you have any of the following:

  • Heart rhythm problems, recent heart attack or congestive heart failure
  • Liver disease
  • Overactive thyroid (hyperthyroidism)
  • Glaucoma or urinary retention issues
  • A history of drug abuse or dependency

Cyclobenzaprine can amplify the effects of alcohol and other CNS depressants (e.g., benzodiazepines, opioids). Avoid driving or operating machinery until you know how this medication affects you.

Potential Drug Interactions

Cyclobenzaprine interacts with several medications. Key ones to mention:

  • MAO inhibitors: Use within 14 days can cause serious (even life-threatening) reactions
  • SSRIs, SNRIs, TCAs: Risk of serotonin syndrome when combined
  • Other CNS depressants: Increased sedation, risk of breathing difficulties

Always provide a full list of your current medications and supplements to your doctor or pharmacist.

What to Do If You Miss a Dose

  • Take it as soon as you remember, unless it’s almost time for your next dose.
  • Do not double up to make up for a missed dose.
  • If you’re on an extended-release form, missing a dose may be less noticeable, but you should still follow the same rules.

Managing Overdose

An overdose of cyclobenzaprine can be serious. Symptoms may include extreme drowsiness, confusion, fast or slow heart rate, seizures, or loss of consciousness. If you suspect an overdose, seek emergency medical attention right away.

Pregnancy and Breastfeeding

  • Pregnancy: Limited data. Use only if the potential benefit justifies potential risks.
  • Breastfeeding: Cyclobenzaprine passes into breast milk. Talk with your doctor about safer options if you’re nursing.

When to Seek Medical Advice

Muscle relaxants like cyclobenzaprine are generally safe when used as directed. However, you should contact a healthcare professional if you experience:

  • Serious allergic reactions (rash, swelling, difficulty breathing)
  • High fever, mental/mood changes, fast heartbeat or chest pain
  • Worsening muscle pain or spasms after the initial relief
  • Any new or unexplained symptoms

For a simple way to get started, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker

. It can help you decide whether to seek immediate medical care or discuss options with your primary doctor.

Tips for Safe Use

  • Take exactly as prescribed, without crushing or chewing extended-release capsules.
  • Store in a cool, dry place away from children.
  • Avoid alcohol and check with your doctor before adding any new medications or supplements.
  • Discuss non-drug measures alongside cyclobenzaprine, such as heat, gentle stretching and physical therapy.

Key Takeaways

  • Cyclobenzaprine is a short-term muscle relaxant for acute muscle spasms.
  • Onset: ~1 hour; peak: 3–8 hours; duration: up to 12–24 hours depending on the form.
  • Common side effects include drowsiness and dry mouth.
  • Use only for 2–3 weeks unless otherwise directed by your doctor.
  • Avoid alcohol and other sedatives.
  • Be aware of potential drug interactions and medical conditions that may affect safety.

Always speak to a doctor about anything that could be serious or life-threatening. Your healthcare provider can help you decide if cyclobenzaprine is right for you, recommend alternative treatments, and monitor you for side effects. If you’re unsure where to start, try a free, online symptom check, using the doctor approved Ubie Symptom Checker

to guide your next steps.

(References)

  • * Winchell GA, King JD, Chavez-Eng CM, Constanzer ML, Korn SH. Cyclobenzaprine pharmacokinetics, including the effects of age, gender, and hepatic insufficiency. J Clin Pharmacol. 2002 Jan;42(1):61-9. doi: 10.1177/0091270002042001007. PMID: 11808825.

  • * Chou R, Peterson K, Helfand M. Comparative efficacy and safety of skeletal muscle relaxants for spasticity and musculoskeletal conditions: a systematic review. J Pain Symptom Manage. 2004 Aug;28(2):140-75. doi: 10.1016/j.jpainsymman.2004.05.002. PMID: 15276195.

  • * See S, Ginzburg R. Skeletal muscle relaxants. Pharmacotherapy. 2008 Feb;28(2):207-13. doi: 10.1592/phco.28.2.207. PMID: 18225966.

  • * Gai MN, Costa E, Arancibia A. Bioavailability of a controlled-release cyclobenzaprine tablet and influence of a high fat meal on bioavailability. Int J Clin Pharmacol Ther. 2009 Apr;47(4):269-74. doi: 10.5414/cpp47269. PMID: 19356393.

  • * Brioschi TM, Schramm SG, Kano EK, Koono EE, Ching TH, Serra CH, Porta V. Pharmacokinetics and bioequivalence evaluation of cyclobenzaprine tablets. Biomed Res Int. 2013;2013:281392. doi: 10.1155/2013/281392. Epub 2013 Sep 16. PMID: 24151591; PMCID: PMC3787571.

  • * Adar L, Zarycranski W, Conner JB, Dragone J, Janka L, Rabinovich-Guilatt L. Bioequivalence of cyclobenzaprine hydrochloride extended-release capsule taken intact or sprinkled over applesauce . Int J Clin Pharmacol Ther. 2017 Dec;55(12):931-938. doi: 10.5414/CP203059. PMID: 29092731.

  • * Mina D, Johansen KL, McCulloch CE, Steinman MA, Grimes BA, Ishida JH. Muscle Relaxant Use Among Hemodialysis Patients: Prevalence, Clinical Indications, and Adverse Outcomes. Am J Kidney Dis. 2019 Apr;73(4):525-532. doi: 10.1053/j.ajkd.2018.11.008. Epub 2019 Jan 11. PMID: 30639233.

  • * Buyukgoz C, Gangu S, Gowani F, Kimura D. Treatment of comatose patient from cyclobenzaprine overdose with therapeutic plasma exchange. J Clin Apher. 2022 Jun;37(3):313-315. doi: 10.1002/jca.21960. Epub 2021 Dec 25. PMID: 34953071.

  • * Miranda Dos Santos E, Ferraz HG, Issa MG, Duque MD. Development of Extended-Release Formulations Containing Cyclobenzaprine Based on Physiologically Based Biopharmaceutics Modeling and Bioequivalence Safe Space. J Pharm Sci. 2023 Dec;112(12):3131-3140. doi: 10.1016/j.xphs.2023.07.012. Epub 2023 Jul 19. PMID: 37473918.

  • * Shah CR, Patel SR, Bhatt LK, Rajwadi VI, Patel UP, Kadu H, Patel JH, Patel H, Ranvir RK, Sundar R, Laddha RN, Jain MR. Preclinical safety, tolerability and pharmacokinetics of a novel cyclobenzaprine hydrochloride nasal spray. Regul Toxicol Pharmacol. 2025 Dec;163:105930. doi: 10.1016/j.yrtph.2025.105930. Epub 2025 Aug 25. PMID: 40865761.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.